You have 4 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CHIR258, CHIR-258, CHIR 258, TKI258, TKI-258, TKI 258,

Showing 26 - 50 of 631
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chemotherapy Teaching: BrUOG 258

Completed
  • Cancer
  • Questionnaire
  • Pawtucket, Rhode Island
  • +3 more
Feb 23, 2022

Adenoid Cystic Carcinoma Trial in Charlottesville (Dovitinib (TKI258))

Completed
Has Results
  • Adenoid Cystic Carcinoma
  • Dovitinib (TKI258)
  • Charlottesville, Virginia
    University of Virginia Health System
Oct 12, 2018

Preparing for Prevention of Huntington's Disease (PREVENT-HD)

Recruiting
  • Huntington Disease
  • Clinical Assessments
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Apr 1, 2022

Health Literacy of Postpartum Women and Family Planing

Completed
  • Contraception
  • +2 more
  • survey application
  • Osmaniye, Turkey
    Derya Kaya Şenol
Mar 23, 2023

Obesity Trial (Usual care, SELF, STEP)

Not yet recruiting
  • Obesity
  • Usual care
  • +2 more
  • (no location specified)
Nov 21, 2023

Advanced NSCLC Trial in Worldwide (EGF816)

Active, not recruiting
Has Results
  • Advanced Non-small Cell Lung Cancer
  • Boston, Massachusetts
  • +13 more
Oct 21, 2022

Lazertinib Dose Modification on Effectiveness and Safety

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Busan, Korea, Republic of
  • +10 more
Jan 29, 2023

Smoking Cessation Trial in Islamabad (E-Cigarette, Nicotine patch)

Not yet recruiting
  • Smoking Cessation
  • E-Cigarette
  • Nicotine patch
  • Islamabad, Federal, Pakistan
    South East Hospital and Research Centre
Apr 9, 2023

Pancreatic Ductal Adenocarcinoma Trial in France (minimally invasive distal pancreatectomy, open distal pancreatectomy)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • minimally invasive distal pancreatectomy
  • open distal pancreatectomy
  • Clichy, France
  • +4 more
Oct 18, 2021

NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • HS-10241+ Almonertinib
  • Pemetrexed + Cisplatin /Carboplatin
  • (no location specified)
Oct 29, 2023

Narcolepsy With Cataplexy Trial in Worldwide (JZP-258, Placebo)

Completed
Has Results
  • Narcolepsy With Cataplexy
  • Orange, California
  • +24 more
Nov 10, 2020

Peptic Ulcers Trial in United States (Celecoxib, Naproxen, ASA)

Completed
  • Peptic Ulcers
  • Anaheim, California
  • +22 more
Mar 1, 2021

NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Nintedanib, gefitinib, erlotinib, afatinib
  • (no location specified)
Oct 2, 2023

NSCLC, EGFR Gene Mutation Trial in Nanjing (neo-antigen vaccine)

Recruiting
  • NSCLC
  • EGFR Gene Mutation
  • neo-antigen vaccine
  • Nanjing, China
    The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital,
Oct 19, 2023

Breast Cancer Trial in Guangzhou (Take probiotics)

Recruiting
  • Breast Cancer
  • Take probiotics
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 6, 2023

Metabolic Alternation and Clinicohematological Characteristic in

Not yet recruiting
  • CML, Chronic Phase
  • Tyrosine kinase inhibitor
  • (no location specified)
Nov 6, 2023

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Coronary Artery Disease Trial in Tehran (Dietary Intervention)

Completed
  • Coronary Artery Disease
  • Dietary Intervention
  • Tehran, Iran, Islamic Republic of
    Shahid Beheshti University of Medical Sciences
Mar 3, 2022

Chronic Myeloid Leukemia Trial in Jena (Venetoclax)

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Jena, Germany
    Universitätsklinikum Jena
Jan 17, 2023

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

Recruiting
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  • Frankfurt, Germany
    Department of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023

Gastrinoma, Glucagonoma, Insulinoma Trial (dovitinib lactate, pharmacological study, laboratory biomarker analysis)

Withdrawn
  • Gastrinoma
  • +5 more
  • dovitinib lactate
  • +2 more
  • (no location specified)
Jul 18, 2017

Brain Metastases, Radiotherapy, EGFR Activating Mutation Trial in Guangdong (brain radiotherapy, Almonertinib)

Recruiting
  • Brain Metastases
  • +2 more
  • Guangdong, Guangzhou, China
    Sun-Yat-Sen university
Mar 13, 2023

NSCLC Trial (Furmonertinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Aug 10, 2023

Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Philadelphia Chromosome-Positive
  • Blinatumomab
  • +3 more
  • New York, New York
  • +1 more
Nov 10, 2022

According to Molecular Identification at Diagnosis

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Next Generation Sequencing (DNA and RNA)
  • (no location specified)
Oct 28, 2022